File Download

There are no files associated with this item.

Supplementary

Conference Paper: Should SGLT-2 inhibitors be used in every patient with diabetes mellitus?

TitleShould SGLT-2 inhibitors be used in every patient with diabetes mellitus?
Authors
Siu, DCW
Issue Date2019
Citation
Hong Kong Society of Endocrinology, Metabolism and Reproduction Symposium, Hong Kong, September 2019 How to Cite?
DescriptionInvited Speaker
Persistent Identifierhttp://hdl.handle.net/10722/309988

 

DC FieldValueLanguage
dc.contributor.authorSiu, DCW-
dc.date.accessioned2022-01-19T09:18:31Z-
dc.date.available2022-01-19T09:18:31Z-
dc.date.issued2019-
dc.identifier.citationHong Kong Society of Endocrinology, Metabolism and Reproduction Symposium, Hong Kong, September 2019-
dc.identifier.urihttp://hdl.handle.net/10722/309988-
dc.descriptionInvited Speaker-
dc.languageeng-
dc.relation.ispartofHong Kong Society of Endocrinology, Metabolism and Reproduction Symposium, 2019-
dc.titleShould SGLT-2 inhibitors be used in every patient with diabetes mellitus?-
dc.typeConference_Paper-
dc.identifier.emailSiu, DCW: cwdsiu@hkucc.hku.hk-
dc.identifier.authoritySiu, DCW=rp00534-
dc.identifier.hkuros314277-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats